Wuxi International Life-Science Innovation Campus (I·Campus) Official website

Home page > About I·Campus > Resources

Resources

Mentor program

AstraZeneca’s senior management team will provide one-on-one mentorship to landing companies, and collaborate with the external innovation experts to share their experience, so as to accelerate the business growth and success of landing companies

Business development and investment

access to the investment assessments from the Global Healthcare Industrial Fund ($ 1 billion) set up by AstraZeneca and China International Capital Corporation, as well as from I•Campus VC partners

Commercial collaboration with AstraZeneca

market insights, product proof of concept and commercial partners platform and commercial innovation ecosystem, including AstraZeneca’s commercial team and Healthcare IoT Center

Incentives

subsidies and incentives covering R&D investment, equipment investment, talent attraction, intellectual property, industrialization of products, listing of company, etc

Infrastructure and platform services

8 major platforms, including new drug development, clinical trial, drug clinical testing, medical device testing, drug certificate service, administrative service, technological and financial service, and professional third-party service platforms

Industrial cluster

Industrial linkage of life science, Internet of things and 5G in Wuxi

Space

The 300,000 sq.m. core R&D area serves as an open space for research and development, office and innovation incubation. The 85,000 sq.m. acceleration area provides space for GMP factories and manufacturing sites. All suitable places in Wuxi and Wuxi New District can serve as the industrialization area

About I·Campus Introduction Ecosystem Partners Team Resources Policies

I·Campus Companies Company Overview Join I·Campus

I·Campus Events Event Review Event Registration

I·Campus News Updates Press

WeChat Official Account

Disclaimer | Privacy Policy | Links

WeChat Official Account